Simian immunodeficiency virus (SIV)-specific CTL are present in large numbers in livers of SIV-infected rhesus monkeys. 2000

J E Schmitz, and M J Kuroda, and R S Veazey, and A Seth, and W M Taylor, and C E Nickerson, and M A Lifton, and P J Dailey, and M A Forman, and P Racz, and K Tenner-Racz, and N L Letvin
Division of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. jschmitz@caregroup.harvard.edu

The immunopathogenesis of AIDS-associated hepatitis was explored in the SIV/rhesus monkey model. The livers of SIV-infected monkeys showed a mild hepatitis, with a predominantly CD8+ T lymphocyte infiltration in the periportal fields and sinusoids. These liver-associated CD8+ T cells were comprised of a high percentage of SIV-specific CTL as defined by MHC class I/Gag peptide tetramer binding and Gag peptide epitope-specific lytic activity. There was insufficient viral replication in these livers to account for attracting this large number of functional virus-specific CTL to the liver. There was also no evidence that the predominant population of CTL were functionally end-stage cells trapped in the liver and destined to undergo apoptotic cell death in that organ. Interestingly, we noted that liver tetramer-binding cells showed an increased expression of CD62L, an adhesion molecule usually only rarely expressed on tetramer-binding cells. This observation suggests that the expression of specific adhesion molecules by CTL might facilitate the capture of these cells in the liver. These results demonstrate that functional SIV-specific CD8+ T cells are present in large numbers in the liver of chronically SIV-infected monkeys. Thus, the liver may be a trap for virus-specific cytotoxic T cells.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D006520 Hepatitis, Animal INFLAMMATION of the LIVER in non-human animals. Animal Hepatitides,Animal Hepatitis,Hepatitides, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D015302 Simian Immunodeficiency Virus Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV. SIV (Simian immunodeficiency virus),Immunodeficiency Viruses, Simian,Simian Immunodeficiency Viruses,Immunodeficiency Virus, Simian
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I
D015683 Gene Products, gag Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or POLYPROTEINS, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen. Viral gag Proteins,gag Antigen,gag Gene Product,gag Gene Products,gag Polyproteins,gag Protein,gag Viral Proteins,Gene Product, gag,Retroviral Antigen gag Protein,gag Antigens,gag Gene Related Protein,gag Polyprotein,Antigen, gag,Antigens, gag,Polyprotein, gag,Polyproteins, gag,Protein, gag,Proteins, Viral gag,Proteins, gag Viral,Viral Proteins, gag,gag Proteins, Viral
D016097 Simian Acquired Immunodeficiency Syndrome Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; (MPMV), or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS. AIDS, Simian,SAIDS,Simian AIDS,Simian Acquired Immune Deficiency Syndrome,Simian Acquired Immuno-Deficiency Syndrome,AIDSs, Simian,Simian AIDSs,Simian Acquired Immuno Deficiency Syndrome

Related Publications

J E Schmitz, and M J Kuroda, and R S Veazey, and A Seth, and W M Taylor, and C E Nickerson, and M A Lifton, and P J Dailey, and M A Forman, and P Racz, and K Tenner-Racz, and N L Letvin
May 1995, Journal of immunology (Baltimore, Md. : 1950),
J E Schmitz, and M J Kuroda, and R S Veazey, and A Seth, and W M Taylor, and C E Nickerson, and M A Lifton, and P J Dailey, and M A Forman, and P Racz, and K Tenner-Racz, and N L Letvin
August 2010, Journal of medical primatology,
J E Schmitz, and M J Kuroda, and R S Veazey, and A Seth, and W M Taylor, and C E Nickerson, and M A Lifton, and P J Dailey, and M A Forman, and P Racz, and K Tenner-Racz, and N L Letvin
December 1991, Laboratory investigation; a journal of technical methods and pathology,
J E Schmitz, and M J Kuroda, and R S Veazey, and A Seth, and W M Taylor, and C E Nickerson, and M A Lifton, and P J Dailey, and M A Forman, and P Racz, and K Tenner-Racz, and N L Letvin
November 1988, Veterinary pathology,
J E Schmitz, and M J Kuroda, and R S Veazey, and A Seth, and W M Taylor, and C E Nickerson, and M A Lifton, and P J Dailey, and M A Forman, and P Racz, and K Tenner-Racz, and N L Letvin
October 1991, Laboratory investigation; a journal of technical methods and pathology,
J E Schmitz, and M J Kuroda, and R S Veazey, and A Seth, and W M Taylor, and C E Nickerson, and M A Lifton, and P J Dailey, and M A Forman, and P Racz, and K Tenner-Racz, and N L Letvin
March 2009, Journal of virology,
J E Schmitz, and M J Kuroda, and R S Veazey, and A Seth, and W M Taylor, and C E Nickerson, and M A Lifton, and P J Dailey, and M A Forman, and P Racz, and K Tenner-Racz, and N L Letvin
March 1993, Journal of virology,
J E Schmitz, and M J Kuroda, and R S Veazey, and A Seth, and W M Taylor, and C E Nickerson, and M A Lifton, and P J Dailey, and M A Forman, and P Racz, and K Tenner-Racz, and N L Letvin
May 2002, Gut,
J E Schmitz, and M J Kuroda, and R S Veazey, and A Seth, and W M Taylor, and C E Nickerson, and M A Lifton, and P J Dailey, and M A Forman, and P Racz, and K Tenner-Racz, and N L Letvin
January 1989, Journal of medical primatology,
J E Schmitz, and M J Kuroda, and R S Veazey, and A Seth, and W M Taylor, and C E Nickerson, and M A Lifton, and P J Dailey, and M A Forman, and P Racz, and K Tenner-Racz, and N L Letvin
August 2000, Journal of medical primatology,
Copied contents to your clipboard!